GL1X · GenesisL1 explorer

MolNFT v1 · #146128 · protein

Discovery of a highly potent and broadly effective EGFR and HER2 exon 20 insertion mutant inhibitor

6D8E · Epidermal growth factor receptor: “Discovery of a highly potent and broadly effective EGFR and HER2 exon 20 insertion mutant inhibitor”. X-ray diffraction, 1 ligand (FZP), 5 pockets (best druggability 0.58). MolNFT v1 #146128 on…

PDB
6D8E
Type
protein
Length
304 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Epidermal growth factor receptor
EC
2.7.10.1
UniProt
P00533
Ligands
FZP
Pockets
5 · best druggability 0.58

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEpidermal growth factor receptor (EC 2.7.10.1)protein30435% helix, 20% strandP00533

Ligands and binding sites

  • FZP · (4-fluorophenyl)methyl {2-[(1-methyl-1H-pyrazol-3-yl) amino]pyrimidin-4-yl}[3-(propanoylamino) phenyl]carbamate · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11790.580.8128empty
22260.580.7924FZP
31230.460.7822empty
4590.370.8022empty
5670.320.7522empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6D8E · Discovery of a Highly Potent and Broadly Effective EGFR and HER2 Exon 20 Insertion Mutant… · the same entry in another collection · chain A against A, TM-score 1.00
  • P00533 · AlphaFold monomer V2.0 prediction for epidermal growth factor receptor (P00533) · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.